CMAR and BBC1 are not breast cancer genes
Author Information
Author(s): E Moerland, MH Breuning, CJ Cornelisse, AM Cleton-Jansen
Primary Institution: Leiden University Medical Center
Hypothesis
Are CMAR and BBC1 the tumour-suppressor genes targeted by loss of heterozygosity in breast cancer?
Conclusion
The study concludes that neither CMAR nor BBC1 are the target tumour-suppressor genes for loss of heterozygosity in breast cancer.
Supporting Evidence
- Loss of heterozygosity on chromosome 16q occurs in 48-65% of breast tumours.
- Mutational analysis revealed no tumour-specific mutations in CMAR and BBC1.
- Another gene at 16q24.3 is likely the actual tumour-suppressor gene targeted by LOH.
Takeaway
The researchers looked at two genes to see if they help stop breast cancer, but they found out that these genes don't actually do that.
Methodology
Mutational analysis of CMAR and BBC1 genes was performed on DNA from 16 breast tumours showing loss of heterozygosity at 16q24.3.
Limitations
The study only analyzed a selected set of breast tumours with LOH at 16q24.3, which may not represent all breast cancer cases.
Participant Demographics
Participants included 16 breast cancer patients with ages ranging from 28 to 82 years.
Want to read the original?
Access the complete publication on the publisher's website